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Occurrence of Emery-Dreifuss muscular 
dystrophy in a rural setting of Cameroon:  
a case report and review of the literature
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Abstract 
Background: Emery-Dreifuss muscular dystrophy is a rare genetic muscular disease, presenting mainly with con-
tractures, weakness and cardiac conduction abnormalities. Its clinical and laboratory similarities to other muscular 
dystrophies, and rarity poses diagnostic challenges, requiring a high index of suspicion in resource limited settings.
Case presentation: An 8 year old sub-Saharan male presented with rigidity and deformity of both elbows and 
ankles, and weakness of the upper limbs and lower limbs for duration of 4 months. This progressed to inability to 
stand and walk. There was no mental impairment. Physical examination was remarkable for contractures of the 
elbows and ankles, and wasting of muscles of the limbs and trunk, with a scapulohumeroperoneal pattern, and tachy-
cardia. After laboratory investigations, a diagnosis of Emery-Dreifuss muscular dystrophy was suspected. Physiother-
apy was started, wheel chair was prescribed, and referral to a specialist center was done for appropriate management.
Conclusions: Emery-Dreifuss muscular dystrophy is a rare disabling muscular disease which poses a diagnostic chal-
lenge. High index of suspicion is paramount for its early diagnoses to prevent orthopedic and cardiac complications. 
Prompt diagnosis and management is essential to improve on the prognosis of this disease.
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Background
Muscular dystrophy (MD) refers to a collective group of 
inherited, non-inflammatory muscular disorders result-
ing from genetic mutations. These mutations lead to a 
dysfunction in or deficiency of essential proteins vital in 
muscle cell stability with consequent progressive mus-
cle degeneration without evidence of morphologic aber-
rations [1]. The occurrence of MD is quite rare with 
reported prevalence ranging between 19.8 and 25.1 per 
100,000 person-years [2]. Amongst others, the varying 
disorders within the MD spectrum differ from each other 
based on the group of muscles affected, age at onset, 
severity of symptoms, pattern of inheritance and other 
organs affected [3].
Emery-Dreifuss muscular dystrophy (EDMD) is a rare 
genetic muscular disease with a worldwide incidence of 
1 in 100,000 [3], presenting in late childhood and adult-
hood [4]. EDMD has three patterns: X-linked recessive, 
autosomal recessive, and autosomal dominant trends 
[5, 6]. Clinically, EDMD present with early contractures 
(involving the elbows, Achilles tendon and posterior cer-
vical muscles), progressive weakness and atrophy with a 
scapulohumeroperoneal distribution, and cardiac con-
duction defects, myopathy or both [7, 8].
Muscular biopsy analysis, muscle enzymes assay, elec-
tro-myography, immunopathology and genetic studies 
play vital roles in the diagnosis of this pathology [8]. The 
clinical and laboratory similarities of EDMD to other 
muscular dystrophies couple with its rarity pose a diag-
nostic challenge. However, early diagnosis of EDMD 
is pivotal in preventing early mortality and morbidity 
from cardiac complications and muscular contractures 
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respectively. Genetic screening of family members is also 
important to help identify family members at risk [9]. We 
herein to the best of our knowledge report the first case 
of EDMD in rural Cameroon presenting at late childhood 
with orthopedic complications as a result of delayed 
diagnosis, and impending cardiac complications neces-
sitating early cardiac interventions so as to avert sudden 
cardiac death.
Case presentation
An 8 year old male Cameroonian presented at the Grace 
Community Health and Development Association out-
reach unit with progressive muscle contractures and 
weakness of the lower limbs, upper limbs and trunk mus-
cles for 4  months. The onset was marked by weakness 
and contractures of the lower limb, progressing within 
a month to involve the upper limbs and trunk muscles. 
This was characterized by flexural deformity of the elbow 
and ankle (Fig. 1b and d). These complaints were associ-
ated progressively with inability to walk or stand without 
support, poor head and waist control, and dysphagia. 
There were no seizures, cognitive impairment, visual or 
auditory impairment, and no bladder or bowel dysfunc-
tion. He was consulted at a district hospital where a 
provisional diagnosis of poliomyelitis was made. How-
ever, stool samples sent to a reference laboratory were 
negative for polio.
His birth history was uneventful. He stood without 
support at 7 months, and walked at 12 months. Assess-
ment of other developmental mile stones was unremark-
able. He had normal motor and mental functions before 
the onset of illness. There was no previous history of 
measles, HIV, trauma or hospitalization. He is fully vac-
cinated for age according to the national guidelines on 
the expanded program on immunization. There was no 
family history of paralytic disease or mental impairment. 
Both parents are alive and well.
On physical examination, the patient was conscious, 
afebrile, with no facial dimorphic features. Pupillary size 
and reflexes were normal. There was no ptosis or facial 
weakness. There was wasting of the upper limb, scapular, 
and spinal muscles and contractures of the elbows and 
ankles (Fig. 1c). There was no calf hypertrophy/pseudo-
hypertrophy. Muscle power was 4/5 on both upper and 
lower limbs. There was weakness of the cervical, lumbar 
and pelvic muscles, evident by poor head control and 
swaying movements of the waist respectively. Hyperto-
nia was evident on the muscles of the arm and calf, with 
Fig. 1 a Poor socio–economic condition of the community. b Muscle wasting and contracture of the elbow joint. c Wasting of the back and gluteal 
muscles, swaying of the hip. d Wasting of calf muscles and deformity of the ankle
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the upper limbs placed in semi flexed position. Sensitiv-
ity to touch, pain, temperature, vibration and proprio-
ception were preserved. Tendon and cutaneous reflexes 
were normal. He was unable to stand or walk without 
support. Gowers sign was absent. Cardiorespiratory 
exam was remarkable for the presence of an irregularly 
irregular tachycardia (heart rate was 122  beats/min). 
There was no palpable abdominal mass or hepatospleno-
megaly. The rest of the physical examinations were unre-
markable. Our differential diagnosis included Duchenne 
muscular dystrophy, EDMD, Fascio-scapula-humeral 
muscular dystrophy (FSHD), congenital myopathies, 
Limb-girdle muscular dystrophy (LGMD), poliomyelitis, 
and trichinellosis.
Laboratory investigations showed serum creatine 
kinase (CK) level of 350 IU/l, hemoglobin count of 13 g/
dl, white blood cell count (8700  cells/µl), and a nor-
mal metabolic profile (Table  1). Hemoxylin–eosin stain 
muscle biopsy analysis revealed non-specific variation 
of muscle fibres diameter (Fig. 2). Atrial tachycardia was 
evident on electrocardiography (ECG) (Fig. 3). Immuno-
histological and genetic studies, and electromyography 
were not done due to lack of finances and diagnostic 
tools.
A diagnosis of EDMD was made based on the early 
development and progression of muscle contractures, 
weakness and wasting with scapulohumeroperoneal 
pattern and cardiac arrhythmia, with atrophic changes 
on muscle biopsy. Expert cardiology and orthopaedic 
referral was done. Physiotherapy and a wheel chair were 
requested. Follow-up one month after referral revealed 
no changes in clinical outcome. Referral for expert man-
agement, physiotherapy, and purchase of wheel chair 
were not done because of financial constraints.
Conclusions
Dreifuss and Hogan are credited with the initial ground-
work on EDMD, when in 1961 they described an unusual 
X-linked form of MD in a large family with muscle wast-
ing disease initially thought to be milder forms of Duch-
enne and Becker muscular dystrophies [10]. It was only 
in 1966 that Alan Emery and Fred Dreifuss identified 
EDMD as a separate disease entity [11].
Emery-Dreifuss muscular dystrophy is a rare type of 
muscular dystrophy with a worldwide incidence of 1 in 
100,000, often presenting in late childhood and adult-
hood [3, 4]. It has three main genetic patterns; X-linked 
recessive, autosomal dominant, and autosomal recessive 
[5, 6]. The X-linked EDMD is the most common pattern, 
occurring due to mutation in the emerin gene chromo-
somes (Xq28) [5]. Emerin protein is located in the inner 
Table 1 Laboratory results of  an 8  year old with  Emery-
Dreifuss muscular dystrophy in Cameroon
Investigation Results Reference values
Haemoglobin concentration 13 g/dl
WBC count 8700 cells/µl 4000–10000 cells/µl
Neutrophils 4800 cells/µl 1500–7500 cells/µl
Eosinophils 2 cells/µl 1–6 cells/µl
Lymphocytes 2500 cells/µl 1200–4000 cells/µl
Platelets 250,000 cells/µl 150000–45000 cells/µl
Fasting blood sugar 98 mg/dl 65–100 mg/dl
Total cholesterol 145 mg/dl 140–199 mg/dl
Triglycerides 98 mg/dl ≤150 mg/dl
Creatine kinase (CK) 350 IU/l 170 IU/l
Stool exam No ova, no larva
HIV serology Negative
Fig. 2 Electrocardiography showing atria tachycardia in an 8 year old 
male with Emery-Dreifuss muscular dystrophy in Cameroon
Fig. 3 Deltoid muscle biopsy with hemoxylin–eosin staining show-
ing variability in muscle fibres size in an 8 year old male with Emery-
Dreifuss muscular dystrophy in Cameroon
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nuclear membrane of body cells, dominant in skeletal and 
cardiac muscles [12]. Mutation in the emerin gene causes 
premature termination of translation in emerin mRNA 
affecting protein synthesis, and causing aberration of 
nuclear functioning [12]. The autosomal dominant and 
recessive patterns of EDMD are due to mutations of the 
Lamin A/C genes [6]. Lamin A/C proteins forms part of 
the inner nuclear membrane, important in the mechani-
cal stability of the nuclear envelop [13] and cell signalling 
[14].
Skeletal muscle involvement in EDMD present clini-
cally with early contractures (involving the ankles, 
elbows, para-spinal muscles), weakness and wasting of 
scapulohumeropareoneal pattern [7, 8]. Muscles weak-
ness may occur at the second decade and may be pre-
ceded by contractures. The main muscles affected are 
biceps, paravertebral, glutei, semitendinosus, adduc-
tor major, and gastrocnemius [15]. Walking difficulties 
and gait disturbances like in our case are common in 
autosomal dominant EDMD [16]. Cardiac conduction 
abnormalities and cardiomyopathy are the main cardiac 
complications of EDMD [17]. Cardiac conduction abnor-
malities common in EDMD include; supraventricular, 
and ventricular tachyarrhythmia, and atrio-ventricular 
block [17]. The presence of cardiac arrhythmias like in 
our case necessitates expert cardiologist consultation. 
Cardiomyopathies (more common in the autosomal 
dominant EDMD) [16] is a primary cause of heart failure 
and usually precedes cardiac arrhythmias.
Muscular dystrophies similar to EDMD include; Duch-
enne muscular dystrophy (DMD), Becker dystrophy 
(BMD), congenital muscular dystrophies, FSHD, LGMD 
[8]. The presence of weakness, hypotonia, and difficulty 
in running, jumping, or calf hypertrophy [18] should 
prompt investigation of DMD. However, these findings 
were absent in our patient. Also the scarcity of contrac-
tures in DMD [18] makes it less likely. Other possible 
diagnosis like congenital myopathies usually present with 
hypotonia and weakness at the neonatal period, which 
is not the case in our patient. Physical abnormalities like 
facial abnormalities, high palate, scoliosis, and delayed 
developmental mile stones are common in congenital 
myopathies [18], but absent in our patient. Fascio-scap-
ula-humeral muscular dystrophy (FSHD) a dominantly 
inherited muscular dystrophy was a potential differential 
in our case. However, its association with facial weakness 
(ability to close the eyes tightly, or smile), slow progres-
sion of weakness, mental retardation, and absence of 
contractures made it less likely [18]. Limb-girdle mus-
cular dystrophy (LGMD), another genetic form of mus-
cular dystrophy is similar to EDMD. It predominantly 
causes weakness of the lower extremities. Although gir-
dle, shoulder and neck muscle weakness can occur [18], 
contractures are less likely. Poliomyelitis usually presents 
with flaccid paralysis, making it less likely in our case.
Creatine kinase levels are normal or mildly elevated (<5 
times the upper limit) in EDMD, as evident in our case. 
CK levels greater than 10 times the upper limit are asso-
ciated with DMD, and BMD [19]. EMG is not required 
for diagnosis [20, 21]. Histological findings are nonspe-
cific, displaying variability in muscle fibre diameters 
[20] as in our case. Molecular genetic studies are used to 
detect mutations of the genes. ECG and echocardiogra-
phy play vital roles to diagnose cardiac complications. A 
team approach involving a neurologist, pulmonologist, 
cardiologist, orthopedic surgeon, physical therapist, and 
counsellors ensures quality care. Emphasis is laid on sur-
gical and nonsurgical management of contractures, and 
pacemaker implantations to prevent sudden death from 
cardiac complications [21].
Our case emphasizes the importance of community 
outreach programs in the recognition of rare diseases 
like EDMD, as this was the historical background in the 
discovery of this disease [10]. Although EDMD has no 
definitive treatment, early diagnosis and interventions 
play an important role in improving the wellbeing of the 
patients [22]. Early recognition of EDMD helps in mini-
mizing contractures through early physical therapy and 
stretching exercises [22]. However, this was not the case 
in our patient as the contractures had markedly pro-
gressed resulting in the patient being handicapped and 
consequently bed bound. Also the presence of cardiac 
signs on ECG puts the patient at risk of sudden death 
from cardiac complications like arrhythmias and other 
cardiac myopathies. Early recognition of these cardiac 
complications is required for timely cardiac interven-
tions like pacemaker implantation to prevent sudden 
cardiac death [22]. Genetic and clinical screening of 
family members is also warranted as it plays an impor-
tant role in early recognition of family members at risk 
[22]. However, genetic studies were not done in our 
case because of limited resources. Furthermore, scien-
tific research in recognizing the genes, mutations, and 
risk factors associated with EDMD should be encour-
aged in the development of novel gene therapies in the 
management of EDMD. The development and support of 
organizations involved in the recognition, awareness and 
management of muscular dystrophies in resource lim-
ited settings will play a good role in finding and assisting 
poor children with EDMD.
Emery-Dreifuss muscular dystrophy is a rare disabling 
genetic muscular disease, and a cause of paralysis, and 
sudden death from cardiac complications. A high index 
of suspicion is required, to pose a diagnosis in patients 
with paralysis in resource limited settings. Prompt 
diagnosis and management is essential to prevent the 
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progression of cardiac and orthopedic complications and 
improve the prognosis of this disease.
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